All articles tagged with #vasopressin
Mayo Clinic researchers identified a vasopressin-independent pathway for kidney water regulation, uncovered when the 1940s drug probenecid altered urate signaling and moved water channels to the cell surface. This could ease PKD treatment by reducing urine volume and nighttime urination, potentially improving quality of life, and it points toward developing targeted therapies beyond current tolvaptan use.
A Liverpool John Moores University study published in the Journal of Applied Physiology shows that healthy adults who drink less than 1.5 liters a day have about a 50% higher cortisol rise during a standardized stress test, likely due to vasopressin; thirst signals are unreliable in busy moments, so monitoring urine color and maintaining consistent hydration—around 1.5–2.5 liters daily, adjusted by sex and health—may blunt cortisol spikes and support stress resilience, though hydration doesn’t replace mental health treatment.
A study uncovers how a mutation in the autism-linked Shank3 gene disrupts vasopressin release in the brain, impairing social behaviors in mice. It reveals that vasopressin acts through two receptors, AVPR1a and AVPR1b, controlling sociability and aggression respectively, and that targeting these receptors could lead to personalized autism therapies.,
Researchers have discovered an oxytocin deficiency in patients with a rare vasopressin deficiency, marking the first time a clinically relevant oxytocin deficiency has been identified. This deficiency could potentially explain symptoms such as anxiety and social interaction difficulties that persist despite treatment. The findings suggest that disorders impacting vasopressin production may concurrently affect oxytocin production due to their close anatomical proximity. This breakthrough could pave the way for new therapeutic approaches, particularly for conditions like autism that are suspected to involve oxytocin deficits.
Researchers from the University of Basel and the University Hospital of Basel have demonstrated a deficiency of oxytocin in patients with a deficiency of vasopressin caused by a disease of the pituitary gland. This finding could be key to developing new therapeutic approaches for patients with vasopressin deficiency and other diseases such as autism. The same researchers are currently planning a large study to investigate whether treatment with oxytocin can improve the psychological symptoms in patients with vasopressin deficiency.